TGI

TRV GP II Portfolio holdings

AUM $1.34M
This Quarter Return
+24%
1 Year Return
-67.55%
3 Year Return
-19.8%
5 Year Return
-49.56%
10 Year Return
–
AUM
$555M
AUM Growth
–
Cap. Flow
+$555M
Cap. Flow %
100%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

1
BPMC
Blueprint Medicines
BPMC
$185M
2
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$130M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
$121M
4
SAGE
Sage Therapeutics
SAGE
$90.2M
5
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$28.1M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$185M 33.32%
+2,453,753
New +$185M
JNCE
2
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$130M 23.49%
+10,230,349
New +$130M
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$121M 21.87%
+2,885,104
New +$121M
SAGE
4
DELISTED
Sage Therapeutics
SAGE
$90.2M 16.25%
+547,916
New +$90.2M
ALNA
5
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$28.1M 5.06%
+2,790,964
New +$28.1M